1. Anti‑metastatic effects of arctigenin are regulated by MAPK/AP‑1 signaling in 4T‑1 mouse breast cancer cells
    Min‑Gu Lee et al, 2020, Molecular Medicine Reports CrossRef
  2. Arctium Species Secondary Metabolites Chemodiversity and Bioactivities
    Dongdong Wang et al, 2019, Frontiers in Plant Science CrossRef
  3. Elucidation of Arctigenin Pharmacokinetics and Tissue Distribution after Intravenous, Oral, Hypodermic and Sublingual Administration in Rats and Beagle Dogs: Integration of In Vitro and In Vivo Findings
    Jie Li et al, 2017, Frontiers in Pharmacology CrossRef
  4. Arctigenin Enhances the Cytotoxic Effect of Doxorubicin in MDA-MB-231 Breast Cancer Cells
    Kyu-Shik Lee et al, 2020, International Journal of Molecular Sciences CrossRef
  5. Molecular mechanisms of the action of Arctigenin in cancer
    Yinghua He et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  6. 28-Day Oral Chronic Toxicity Study of Arctigenin in Rats
    Yu-jun Tan et al, 2018, Frontiers in Pharmacology CrossRef
  7. Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells
    Thressi Maxwell et al, 2018, International Journal of Oncology CrossRef
  8. Arctigenin-mediated cell death of SK-BR-3 cells is caused by HER2 inhibition and autophagy-linked apoptosis
    Min-Gu Lee et al, 2021, Pharmacological Reports CrossRef
  9. Recent Progress on the Molecular Mechanisms of Anti-invasive and Metastatic Chinese Medicines for Cancer Therapy
    Wei Guo et al, 2017, Unique Aspects of Anti-cancer Drug Development CrossRef
  10. Arctigenin attenuates platelet activation and clot retraction by regulation of thromboxane A2 synthesis and cAMP pathway
    Gi Suk Nam et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  11. The Effects of Trifolium pratense L. Sprouts’ Phenolic Compounds on Cell Growth and Migration of MDA-MB-231, MCF-7 and HUVEC Cells
    Małgorzata Zakłos-Szyda et al, 2020, Nutrients CrossRef
  12. Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling
    Hui Shi et al, 2020, International Journal of Molecular Sciences CrossRef
  13. Medicinal Herbs Used in Traditional Management of Breast Cancer: Mechanisms of Action
    Donovan A. McGrowder et al, 2020, Medicines CrossRef
  14. Calycosin inhibits viability, induces apoptosis, and suppresses invasion of cervical cancer cells by upregulating tumor suppressor miR-375
    Dongli Zhang et al, 2020, Archives of Biochemistry and Biophysics CrossRef
  15. Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment
    Arezoo Gowhari Shabgah et al, 2021, European Journal of Pharmacology CrossRef
  16. A Review of Natural Therapies Potentially Relevant in Triple Negative Breast Cancer Aimed at Targeting Cancer Cell Vulnerabilities
    Myfanwy Jane Webb et al, 2020, Integrative Cancer Therapies CrossRef
  17. Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
    František Zálešák et al, 2019, Pharmacological Research CrossRef
  18. Phytoestrogens: The current state of research emphasizing breast pathophysiology
    Harini Anandhi Senthilkumar et al, 2018, Phytotherapy Research CrossRef
  19. A comprehensive mechanistic insight into the dietary and estrogenic lignans, arctigenin and sesamin as potential anticarcinogenic and anticancer agents. Current status, challenges, and future perspectives
    Sayeh Mottaghi et al, 2021, Critical Reviews in Food Science and Nutrition CrossRef
  20. Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives
    Paramita Basu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  21. Arctigenin promotes bone formation involving PI3K/Akt/PPARγ signaling pathway
    Hongbo Li et al, 2020, Chemical Biology & Drug Design CrossRef
  22. Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review
    Sayeh Mottaghi et al, 2021, Nutrition and Cancer CrossRef
  23. 3,3′-Diindolylmethane Suppressed Cyprodinil-Induced Epithelial-Mesenchymal Transition and Metastatic-Related Behaviors of Human Endometrial Ishikawa Cells via an Estrogen Receptor-Dependent Pathway
    Bo-Gyoung Kim et al, 2018, International Journal of Molecular Sciences CrossRef
  24. Arctigenin represses TGF-β-induced epithelial mesenchymal transition in human lung cancer cells
    Yanrui Xu et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  25. Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation
    Lei Zhu et al, 2020, Life Sciences CrossRef
  26. Development of leads targeting ER-α in breast cancer: An in silico exploration from natural domain
    Snehal S. Ashtekar et al, 2018, Steroids CrossRef